Finoriq research workspace
Medpace Holdings, Inc. (MEDP) News
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in. Review MEDP recent headlines, source links, and company news on Finoriq.
Company Snapshot
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
- Company
- Medpace Holdings, Inc. (MEDP)
- Ticker
- MEDP
- Market Cap
- $15.1B
- Latest Price
- $528.8
- Industry
- Biotech & Pharma
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.